MPG.eBooks - Search Results

1

CADTH Canadian Drug Expert Committee recommendation: Latanoprostene bunod (Vyzulta -- Bausch Health, Canada Inc.) : indication : for the reduction of intraocular pressure (IOP) in...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma / drug therapy...”

Read Now

2

CADTH Canadian Drug Expert Committee final recommendation: Infliximab : Inflectra : Hospira Healthcare Corporation

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Crohn Disease / drug therapy...”

Read Now

3

CADTH Canadian Drug Expert Committee final recommendation: Dapagliflozin (Forxiga -- AstraZeneca Canada Inc.) indication : type 2 diabetes

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Combinations...”

Read Now

4

CADTH Canadian Drug Expert Committee recommendation: Netupitant/palonosetron (Akynzeo -- Purdue Pharma) : indication : chemotherapy-induced nausea and vomiting

Published 2018

CADTH

Subjects: “...Nausea / drug therapy...”

Read Now

5

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma / drug therapy...”

Read Now

6

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...

Published 2019

CADTH

Subjects: “...HIV-1 / drug effects...”

Read Now

7

CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Combinations...”

Read Now

8

CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Glaucoma / drug therapy...”

Read Now

9

CADTH Canadian Drug Expert Committee recommendation: Dexamethasone (Ozurdex -- Allergan Canada Inc.) indication: for the treatment of adult patients with diabetic macular edema who...

Published 2018

CADTH

Subjects: “...Diabetes Complications / drug therapy...”

Read Now

10

CADTH Canadian Drug Expert Review Committee final recommendation: Riociguat (Adempas - Bayer HealthCare Inc.) : indication: pulmonary arterial hypertension

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Evaluation...”

Read Now

11

CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Intra-Abdominal Fat / drug effects...”

Read Now

12

CADTH Canadian Drug Expert Committee recommendation: Insulin degludec and liraglutide (Xultophy -- Novo Nordisk Canada Inc.) : indication : adjunct to lifestyle modifications, for...

Published 2019

CADTH

Subjects: “...Drug Combinations...”

Read Now

13

CADTH Canadian Drug Expert Committee final recommendation: Tiotropium/Olodaterol (Inspiolto Respimat - Boehringer Ingelheim Canada Ltd.) indication : chronic obstructive pulmonary...

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Drug Combinations...”

Read Now

14

CADTH Canadian Drug Expert Committee recommendation: Travoprost 0.003% (Izba -- Novartis Pharmaceuticals Canada inc. on behalf of Alcon Canada Inc.) : indication : for the reductio...

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Ocular Hypertension / drug therapy...”

Read Now

15

CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...

Published 2018

CADTH

Subjects: “...Tyrosinemias / drug therapy...”

Read Now

16

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Arthritis, Rheumatoid / drug therapy...”

Read Now

17

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Arthritis, Rheumatoid / drug therapy...”

Read Now

18

CADTH Canadian Drug Expert Committee final recommendation: Canagliflozin and metformin hydrochloride (Invokamet -- Janssen Inc.) : type 2 diabetes mellitus

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Diabetes Mellitus, Type 2 / drug therapy...”

Read Now

19

CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Urinary Incontinence / drug therapy...”

Read Now

20

CADTH Canadian Drug Expert Committee final recommendation: Propiverine hydrochloride (Mictoryl/Mictoryl Pediatric--Duchesnay Inc.)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Urinary Incontinence / drug therapy...”

Narrow Search